This is the information currently posted on the the clinical trails gov website regarding their diabetic foot ulcer study. Hopefully we'll get an update in the near future.
Study Type: Interventional (Clinical Trial) 1 EstimatedEnrollment: 138 participants 2 Allocation: Randomized 3 Intervention Model: Parallel Assignment 4 Masking: None (Open Label) 5 Primary Purpose: Treatment 6 Official Title: A Prospective, Multicenter, Open Label, Randomized, Controlled Clinical Study Evaluating the Effect of NovoSorb ® SynPath™ Dermal Matrix Compared to Standard of Care (SOC) In the Treatment of Nonresponsive, Chronic Diabetic Foot Ulcers. 7 ActualStudy Start Date: July 10, 2022 8 EstimatedPrimary Completion Date: December 1, 2023 9 EstimatedStudy Completion Date: March 1, 2024
PNV - Banter and General Comments, page-10865
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.06 |
Change
-0.015(0.72%) |
Mkt cap ! $1.429B | |||
| Open | High | Low | Value | Volume |
| $2.09 | $2.11 | $2.04 | $922.6K | 443.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 12744 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.06 | 17582 | 20 |
View Market Depth
| Last trade - 13.40pm 15/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |